![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00345-022-04113-0/MediaObjects/345_2022_4113_Fig1_HTML.png)
References
Liss MA, Taylor SA, Batura D et al (2014) Fluoroquinolone resistant rectal colonization predicts risk of infectious complications after transrectal prostate biopsy. J Urol 192:1673–1678. https://doi.org/10.1016/j.juro.2014.06.005
Kisa E, Altug MU, Gurbuz OA et al (2017) Fosfomycin: a good alternative drug for prostate biopsy prophylaxis the results of a prospective, randomized trial with respect to risk factors. Int Braz J Urol 43(6):1068–1074. https://doi.org/10.1590/S1677-5538.IBJU.2016.0619
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kisa, E. Are the use of fluoroquinolones in prostate biopsy prophylaxis returning? Comment on “antibiotic prophylaxis in patients who had undergone to prostate biopsy in between the EMA warning era: effects of fluoroquinolones in diabetic and non-diabetic patients. Results of an observational cohort study”. World J Urol 40, 2583–2584 (2022). https://doi.org/10.1007/s00345-022-04113-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-022-04113-0